Am. J. Respir. Crit. Care Med., Volume 156, Number 1, July 1997, 260-265

Effects of Neutrophil Elastase Inhibitor on Bleomycin-Induced Pulmonary Fibrosis in Mice

YASUYUKI TAOOKA, AKIHIRO MAEDA, KEIKO HIYAMA, SHINICHI ISHIOKA, and MICHIO YAMAKIDO

Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima, Japan

Neutrophils play an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). To elucidate the possible involvement of neutrophil elastase (NE) in pulmonary fibrosis, we investigated the efficacy of a new specific NE inhibitor (ONO-5046 · Na) in a murine model of human IPF, bleomycin-induced pulmonary fibrosis. Bronchoalveolar lavage (BAL) and histopathological analysis were performed on bleomycin-treated mice (group A), bleomycin and ONO-5046 · Na-treated mice (group B), and saline control groups at 1, 15, and 29 d after the end of bleomycin treatment. At 29 d, multifocal fibrosis was observed in group A, whereas no fibrotic regions were observed in group B. Interleukin-1 and macrophage inflammatory protein-2 mRNA levels in BAL cells on day 1, and platelet-derived growth factor-A and insulin-like growth factor-I mRNA levels on days 1 and 15, were significantly lower in group B than in group A. Thus, we demonstrated an inhibitory effect of ONO-5046 · Na on pulmonary fibrosis in mice, indicating the involvement of NE in the pathogenesis of pulmonary fibrosis. We propose that this effect might be related to suppressed expression of particular cytokines in alveolar macrophages and that this specific NE inhibitor could be a novel therapeutic agent for IPF.

This article has been cited by other articles:

				N Oikonomou, A Thanasopoulou, A Tzouvelekis, V Harokopos, T Paparountas, I Nikitopoulou, W Witke, A Karameris, A Kotanidou, D Bouros, et al. Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis Thorax, June 1, 2009; 64(6): 467 - 475. [Abstract] [Full Text] [PDF]

				G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315. [Abstract] [Full Text] [PDF]

				N. Pottier, C. Chupin, V. Defamie, B. Cardinaud, R. Sutherland, G. Rios, F. Gauthier, P. J. Wolters, Y. Berthiaume, P. Barbry, et al. Relationships between Early Inflammatory Response to Bleomycin and Sensitivity to Lung Fibrosis: A Role for Dipeptidyl-Peptidase I and Tissue Inhibitor of Metalloproteinase-3? Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1098 - 1107. [Abstract] [Full Text] [PDF]

				M. Horikawa, M. Fujimoto, M. Hasegawa, T. Matsushita, Y. Hamaguchi, A. Kawasuji, Y. Matsushita, T. Fujita, F. Ogawa, K. Takehara, et al. E- and P-Selectins Synergistically Inhibit Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., September 1, 2006; 169(3): 740 - 749. [Abstract] [Full Text] [PDF]

				F. Chua and G. J. Laurent Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proceedings of the ATS, July 1, 2006; 3(5): 424 - 427. [Abstract] [Full Text] [PDF]

				G. J. Laurent No Bit PARt for PAR-1 Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 213 - 215. [Full Text] [PDF]

				S. Murakami, N. Nagaya, T. Itoh, T. Fujii, T. Iwase, K. Hamada, H. Kimura, and K. Kangawa C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1172 - L1177. [Abstract] [Full Text] [PDF]

				N. Hashimoto, T. Kawabe, K. Imaizumi, T. Hara, M. Okamoto, K. Kojima, K. Shimokata, and Y. Hasegawa CD40 Plays a Crucial Role in Lipopolysaccharide-Induced Acute Lung Injury Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 808 - 815. [Abstract] [Full Text] [PDF]

				Y. Inoue, T. E. King Jr., E. Barker, E. Daniloff, and L. S. Newman Basic Fibroblast Growth Factor and Its Receptors in Idiopathic Pulmonary Fibrosis and Lymphangioleiomyomatosis Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 765 - 773. [Abstract] [Full Text] [PDF]

				H Mukae, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, and S Kohno Raised plasma concentrations of {alpha}-defensins in patients with idiopathic pulmonary fibrosis Thorax, July 1, 2002; 57(7): 623 - 628. [Abstract] [Full Text] [PDF]

				H.-D. WANG, M. YAMAYA, S. OKINAGA, Y.-X. JIA, M. KAMANAKA, H. TAKAHASHI, L.-Y. GUO, T. OHRUI, and H. SASAKI Bilirubin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 406 - 411. [Abstract] [Full Text] [PDF]

				S. E. Dunsmore, J. Roes, F. J. Chua, A. W. Segal, S. E. Mutsaers, and G. J. Laurent Evidence That Neutrophil Elastase-Deficient Mice Are Resistant to Bleomycin-Induced Fibrosis Chest, July 1, 2001; 120 (2009): 35S - 36S. [Full Text] [PDF]

				E. Cavarra, P.A. Martorana, B. Bartalesi, S. Fineschi, F. Gambelli, M. Lucattelli, L. Ortiz, and G. Lungarella Genetic deficiency of {alpha}1-PI in mice influences lung responses to bleomycin Eur. Respir. J., March 1, 2001; 17(3): 474 - 480. [Abstract] [Full Text] [PDF]

				Y. SHIMIZU, K. DOBASHI, K. IIZUKA, T. HORIE, K. SUZUKI, H. TUKAGOSHI, T. NAKAZAWA, Y. NAKAZATO, and M. MORI Contribution of Small GTPase Rho and Its Target Protein ROCK in a Murine Model of Lung Fibrosis Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 210 - 217. [Abstract] [Full Text]

				K. TAMAGAWA, Y. TAOOKA, A. MAEDA, K. HIYAMA, S. ISHIOKA, and M. YAMAKIDO Inhibitory Effects of a Lecithinized Superoxide Dismutase on Bleomycin-Induced Pulmonary Fibrosis in Mice Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1279 - 1284. [Abstract] [Full Text]